BACKGROUND: Human breastmilk provides a rich source of commensal lactic acid bacteria (LAB) to the infant during breastfeeding and stimulates abundant growth and colonization of these bacteria at mucosal surfaces in the infant gastrointestinal tract. While conferring critical nutritional and immunologic support to the developing newborn, breastmilk also serves as a vehicle for human immunodeficiency virus type 1 (HIV-1) transmission from mother to child during breastfeeding. Whether breastmilk LAB confer protection against mucosal exposure to HIV-1 in breastfeeding infants is unknown. STUDY DESIGN: In the present study, we sought to evaluate LAB isolated from the breastmilk of healthy women for the ability to inhibit HIV-1 infection in vitro. A total of 38 strains of breastmilk bacteria were evaluated in this study. Both heat-killed bacteria and cell-free conditioned supernatants from bacterial cultures were tested for the ability to inhibit infection with HIV-1 using viral isolates with tropism for CCR5 (R5), CXCR4 (X4), or R5/X4 dual-tropism. RESULTS: Significant inhibition of R5-tropic HIV-1 was demonstrated using heat-killed bacteria, most notably among breastmilk strains of Lactobacillus and Pediococcus. Selected strains of breastmilk LAB also demonstrated significant inhibition of HIV-1 infection against virus with tropism for X4 and R5/X4. CONCLUSION: These results demonstrate for the first time that commensal LAB from human breastmilk inhibit HIV-1 infection in vitro and suggest a possible role for these bacteria in mucosal protection against HIV-1 in the breastfeeding infant.
BACKGROUND:Human breastmilk provides a rich source of commensal lactic acid bacteria (LAB) to the infant during breastfeeding and stimulates abundant growth and colonization of these bacteria at mucosal surfaces in the infantgastrointestinal tract. While conferring critical nutritional and immunologic support to the developing newborn, breastmilk also serves as a vehicle for human immunodeficiency virus type 1 (HIV-1) transmission from mother to child during breastfeeding. Whether breastmilk LAB confer protection against mucosal exposure to HIV-1 in breastfeeding infants is unknown. STUDY DESIGN: In the present study, we sought to evaluate LAB isolated from the breastmilk of healthy women for the ability to inhibit HIV-1 infection in vitro. A total of 38 strains of breastmilk bacteria were evaluated in this study. Both heat-killed bacteria and cell-free conditioned supernatants from bacterial cultures were tested for the ability to inhibit infection with HIV-1 using viral isolates with tropism for CCR5 (R5), CXCR4 (X4), or R5/X4 dual-tropism. RESULTS: Significant inhibition of R5-tropic HIV-1 was demonstrated using heat-killed bacteria, most notably among breastmilk strains of Lactobacillus and Pediococcus. Selected strains of breastmilk LAB also demonstrated significant inhibition of HIV-1 infection against virus with tropism for X4 and R5/X4. CONCLUSION: These results demonstrate for the first time that commensal LAB from human breastmilk inhibit HIV-1 infection in vitro and suggest a possible role for these bacteria in mucosal protection against HIV-1 in the breastfeeding infant.
Authors: Athena P Kourtis; Denise J Jamieson; Isabelle de Vincenzi; Allan Taylor; Michael C Thigpen; Halima Dao; Timothy Farley; Mary Glenn Fowler Journal: Am J Obstet Gynecol Date: 2007-09 Impact factor: 8.661
Authors: E Jiménez; L Fernández; A Maldonado; R Martín; M Olivares; J Xaus; J M Rodríguez Journal: Appl Environ Microbiol Date: 2008-06-06 Impact factor: 4.792
Authors: Ashton Harper; Vineetha Vijayakumar; Arthur C Ouwehand; Jessica Ter Haar; David Obis; Jordi Espadaler; Sylvie Binda; Shrilakshmi Desiraju; Richard Day Journal: Front Cell Infect Microbiol Date: 2021-02-12 Impact factor: 6.073
Authors: Raquel González; Antonio Maldonado; Virginia Martín; Inácio Mandomando; Victoria Fumadó; Karin J Metzner; Charfudin Sacoor; Leónides Fernández; Eusébio Macete; Pedro L Alonso; Juan M Rodríguez; Clara Menendez Journal: PLoS One Date: 2013-11-26 Impact factor: 3.240
Authors: Santosh Kumar Tiwari; Leon M T Dicks; Igor V Popov; Alena Karaseva; Alexey M Ermakov; Alexander Suvorov; John R Tagg; Richard Weeks; Michael L Chikindas Journal: Front Microbiol Date: 2020-08-20 Impact factor: 6.064